Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4226
PUT
NIO
NIO
$7.64B
| $70K | ﹤0.01% |
20,400
-10,500
| -34% | -$45.8K |
2022 Q1
18 quarters
|
|
4227
Brazil Potash Corp
GRO
$109M
| $69.7K | ﹤0.01% |
31,524
-44,106
| -58% | -$101K |
2026 Q2
1 quarter
|
|
4228
Sionna Therapeutics
SION
$155M
| $68.4K | ﹤0.01% |
13,013
+7,598
| +140% | +$174K |
2025 Q3
4 quarters
|
|
4229
ATRenew
RERE
$855M
| $67.6K | ﹤0.01% |
18,124
-12,165
| -40% | -$49.9K |
2025 Q3
4 quarters
|
|
4230
Angi Inc
ANGI
$259M
| $67K | ﹤0.01% |
11,629
-15,542
| -57% | -$83.3K |
2026 Q2
1 quarter
|
|
4231
Energys Group
ENGS
$26.3M
| $66.6K | ﹤0.01% |
+21,903
| New | +$61.1K |
2026 Q3
0 quarters
|
|
4232
Abeona Therapeutics
ABEO
$141M
| $65.9K | ﹤0.01% |
+12,550
| New | +$77.9K |
2026 Q3
0 quarters
|
|
4233
Aldeyra Therapeutics
ALDX
$38M
| $64.9K | ﹤0.01% |
52,776
-41,272
| -44% | -$65.9K |
2026 Q2
1 quarter
|
|
4234
CALL
T1 Energy
TE
$590M
| $64.5K | ﹤0.01% |
+16,700
| New | +$86K |
2026 Q3
0 quarters
|
|
4235
CALL
Medical Properties Trust
MPT
$1.01B
| $64K | ﹤0.01% |
+18,500
| New | +$77.8K |
2026 Q3
0 quarters
|
|
4236
Funko
FNKO
$389M
| $62.6K | ﹤0.01% |
+11,580
| New | +$67.4K |
2026 Q3
0 quarters
|
|
4237
Grandstand Ltd
GRSD
$29M
| $62.5K | ﹤0.01% |
41,364
-31,584
| -43% | -$58.5K |
2026 Q2
1 quarter
|
|
4238
Huya Inc
HUYA
$507M
| $62.1K | ﹤0.01% |
27,234
-11,625
| -30% | -$26.7K |
2025 Q4
3 quarters
|
|
4239
Tenaya Therapeutics
TNYA
$79.2M
| $61K | ﹤0.01% |
101,066
-558,181
| -85% | -$407K |
2026 Q1
2 quarters
|
|
4240
Dominari Holdings
DOMH
$19M
| $60.5K | ﹤0.01% |
+27,648
| New | +$70.3K |
2026 Q3
0 quarters
|
|
4241
Rapid Micro Biosystems
RPID
$33.7M
| $60.1K | ﹤0.01% |
+58,359
| New | +$95.5K |
2026 Q3
0 quarters
|
|
4242
ThredUp
TDUP
$200M
| $59.4K | ﹤0.01% |
28,017
-424,303
| -94% | -$1.74M |
2023 Q4
11 quarters
|
|
4243
Cronos Group
CRON
$1.25B
| $58.7K | ﹤0.01% |
17,793
-24,868
| -58% | -$76.8K |
2025 Q4
3 quarters
|
|
4244
WiMi Hologram Cloud
WIMI
$9.1M
| $58.6K | ﹤0.01% |
78,959
+38,833
| +97% | +$47.3K |
2026 Q2
1 quarter
|
|
4245
CALL
Under Armour
UAA
$2.1B
| $57.5K | ﹤0.01% |
12,900
-27,000
| -68% | -$156K |
2024 Q4
7 quarters
|
|
4246
PUT
Lucid Motors
LCID
$1.29B
| $57K | ﹤0.01% |
14,000
-39,100
| -74% | -$221K |
2026 Q2
1 quarter
|
|
4247
Kalaris Therapeutics
KLRS
$39.5M
| $54.8K | ﹤0.01% |
18,947
-19,828
| -51% | -$76.7K |
2024 Q4
7 quarters
|
|
4248
Redwood Trust
RWT
$332M
| $54K | ﹤0.01% |
13,905
-19,130
| -58% | -$86.6K |
2026 Q2
1 quarter
|
|
4249
GoodRx Holdings
GDRX
$1.2B
| $53.4K | ﹤0.01% |
16,246
-58,524
| -78% | -$195K |
2025 Q4
3 quarters
|
|
4250
Nu Skin
NUS
$195M
| $53.3K | ﹤0.01% |
+11,775
| New | +$58.2K |
2026 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.